KalVista Pharmaceuticals Inc
KALVLatest QuantConomy context for KALV: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
KalVista Pharmaceuticals Inc
QuantConomy has a structured record for KALV. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- KALV
- Name
- KalVista Pharmaceuticals Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq
Recent signals for KALV
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| net income change | very bullish | 76 | May 14, 12:00 AM | KALV (Q1 2026, net income): grew 78.6% (-$109.52M → -$23.49M). [sequential period basis, very bullish signal] |
| eps change | very bullish | 76 | May 14, 12:00 AM | KALV (Q1 2026, diluted eps): EPS grew 78.8% ($-2.03 → $-0.43). [sequential period basis, very bullish signal] |
| operating income change | very bullish | 76 | May 14, 12:00 AM | KALV (Q1 2026, operating income): grew 79.1% (-$112.04M → -$23.44M). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| KALV | NASDAQ | fmp | KalVista Pharmaceuticals, Inc. |
| KALV | NASDAQ | alphavantage | KalVista Pharmaceuticals Inc |
| KALV | NASDAQ | alpaca | KalVista Pharmaceuticals, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | other | 150,260 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | Unkart Edward W | Director | other | 12,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Sensenig Bethany | Director | other | 45,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Arif Bilal | Chief Operations Officer | other | 100,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | other | 479,989 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | Stuart Nancy | Director | other | 14,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Reid Laurence | Director | other | 17,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Fairey William | Director | other | 17,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Treanor Patrick | Director | other | 17,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Pereira Brian JG | Director | other | 14,000 | — | — | 4 on EDGAR |
| Jun 11, 2026 | Sweeny Nicole | Chief Commercial Officer | other | 59,291 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | other | 229,918 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | Piekos Brian | Chief Financial Officer | other | 21,661 | $0.00 | $0 | 4 on EDGAR |
| May 27, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | exercise | 33,800 | $7.07 | $238,966 | 4 on EDGAR |
| May 22, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | exercise | 5,000 | — | — | 4 on EDGAR |
| May 22, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | exercise | 3,125 | — | — | 4 on EDGAR |
| May 22, 2026 | Sweeny Nicole | Chief Commercial Officer | exercise | 5,000 | — | — | 4 on EDGAR |
| May 21, 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | exercise | 3,750 | — | — | 4 on EDGAR |
| May 21, 2026 | Sweeny Nicole | Chief Commercial Officer | exercise | 6,250 | — | — | 4 on EDGAR |
| May 21, 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | exercise | 6,250 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query KALV context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access